PTEN Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Male only (1)
Any (1)

Phase 3 (2)

Interventional (2)

AstraZeneca (1)
Novartis Pharmaceuticals (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadorchiectomy

I am/have/hadtriple negative breast cancer

I am/have/hadfatigue

I am/have/hadandrogen suppression

I am/have/hadpik3ca

I am/have/hadPTEN

I am/have/hadcancer

I am/have/hadbone lesion

I am/have/hadsolid tumour

I am/have/hadprostate cancer

I am/have/hadmeasurable disease

I am/have/hadadenocarcinoma of prostate

I am/have/hadadenocarcinoma

I am/have/hadmetastasis

I am/have/hadsoft tissue lesion

I am/have/hadbreast cancer

I am/have/hadsteroid therapy

I am/have/hadbone metastases

added new label for I am/have/had

I am looking for

I am looking forsteroid therapy

I am looking forpik3ca

I am looking forgonadotropin releasing hormone

I am looking foralpelisib

I am looking foranalgesics

I am looking forprednisone

I am looking forprednisolone

I am looking forantiandrogen therapy

I am looking forluteinizing hormone-releasing hormone agonist

I am looking forpaclitaxel

added new label for I am looking for

Advanced Filters

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 3
For Seniors
For adults
Recruiting in 1000s
Interventional Study
For Males
Recruiting

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

This study will assess the efficacy and safety of capivasertib plus abiraterone (+prednisone/prednisolone) plus androgen deprivation therapy (ADT) versus placebo plus abiraterone (+prednisone/prednisolone) plus ADT in participants with mHSPC whose tumours are characterised by PTEN deficiency. The intention of the study is to demonstrate that in participants with mHSPC, the …

orchiectomy

fatigue

steroid therapy

androgen suppression

cancer

0 views
16 Feb, 2024
107 locations

Multi-country trial
Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Cardiovascular Diseases
Recruiting

Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss Without PIK3CA Mutation

The purpose of this study is to determine whether treatment with alpelisib in combination with nab-paclitaxel is safe and effective in subjects with advanced triple negative breast cancer (aTNBC) who carry either a PIK3CA mutation (Study Part A) or have PTEN loss without PIK3CA mutation (Study Parts B1 and B2)

triple negative breast cancer

metastasis

pik3ca

cancer

PTEN

0 views
16 Feb, 2024
3 locations